Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensCell Lines for BBB Modeling
- Immortalized Cells for BBB ModelingPrimary Cells for BBB ModelingStem Cells for BBB ModelingProteins & Peptides for Stroke ResearchOnline Inquiry
Human Substance P ELISA Kit (AC3222)
Cat.#: ASET-1811
Specifications
Description Human Substance P ELISA Kit, a 90-minute assay kit, allows for the in vitro quantitative determination of human Substance P concentrations in serum, plasma, and other biological fluids. Size 96T Sample Type Serum, plasma or other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 10.47 ng/L Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 200-3200 ng/L Assay Time ~90 min Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-2313 Human Neuropeptide Y ELISA Kit (AC3724) Quantitative inquiry ASET-1119 Mouse Hes1 ELISA Kit (AC2530) Quantitative inquiry ASET-2033 Rat Agrin ELISA Kit (AC3444) Quantitative inquiry ASET-1656 Rat Neuritin ELISA Kit (AC3067) Quantitative inquiry ASET-2052 Mouse OPA1 ELISA Kit (AC3463) Quantitative inquiry ASET-2151 Mouse Adenosine A1 Receptor ELISA Kit (AC3562) Quantitative inquiry ASET-1024 Chicken FGF2 ELISA Kit (AC2435) Quantitative inquiry ASET-2259 Human NRSN2 ELISA Kit (AC3670) Quantitative inquiry ASET-2442 Human Ephrin B2 ELISA Kit (AC3853) Quantitative inquiry ASET-1740 Rabbit Myelin Basic Protein ELISA Kit (AC3151) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket